Total Payments
$4,627
2024 Payments
$831.77
Companies
22
Transactions
112
Medicare Patients
2,919
Medicare Billing
$205,969
Payment Breakdown by Category
Food & Beverage$4,627 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,627 | 112 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch & Lomb, a division of Bausch Health US, LLC | $863.62 | 17 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $635.28 | 9 | $0 (2024) |
| ABBVIE INC. | $612.29 | 11 | $0 (2024) |
| Allergan, Inc. | $485.30 | 17 | $0 (2022) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $221.99 | 6 | $0 (2024) |
| Shire North American Group Inc | $189.55 | 7 | $0 (2018) |
| Aerie Pharmaceuticals, Inc. | $188.15 | 5 | $0 (2021) |
| RxSight Inc | $172.28 | 4 | $0 (2024) |
| Oyster Point Pharma, Inc. | $161.60 | 7 | $0 (2024) |
| Amgen Inc. | $152.28 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $831.77 | 15 | ABBVIE INC. ($245.31) |
| 2023 | $579.49 | 12 | Bausch & Lomb Americas Inc. ($165.88) |
| 2022 | $1,051 | 26 | Bausch & Lomb Americas Inc. ($314.84) |
| 2021 | $474.08 | 13 | Bausch & Lomb, a division of Bausch Health US, LLC ($207.62) |
| 2020 | $84.26 | 3 | Allergan, Inc. ($43.48) |
| 2019 | $385.60 | 11 | Aerie Pharmaceuticals, Inc. ($176.68) |
| 2018 | $1,015 | 25 | Bausch & Lomb, a division of Bausch Health US, LLC ($488.40) |
| 2017 | $206.18 | 7 | Valeant Pharmaceuticals North America LLC ($134.62) |
All Payment Transactions
112 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/29/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: Ophthalmology | ||||||
| 08/30/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/17/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $146.47 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/28/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/27/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/05/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: EYE CARE | ||||||
| 05/30/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: EYE CARE | ||||||
| 05/29/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $108.85 | General |
| Category: EYE CARE | ||||||
| 05/09/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $144.34 | General |
| Category: Ophthalmology | ||||||
| 05/01/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $124.71 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/23/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $5.81 | General |
| Category: Inflammation/Rare Disease | ||||||
| 04/10/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $31.97 | General |
| Category: Dry eyes | ||||||
| 03/23/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $10.22 | General |
| Category: Ophthalmology | ||||||
| 01/31/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Dry eyes | ||||||
| 12/13/2023 | AbbVie Inc. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: EYE CARE | ||||||
| 11/05/2023 | Bausch & Lomb Americas Inc. | INFUSE (Device), BIOTRUE ONE DAY | Food and Beverage | In-kind items and services | $121.11 | General |
| Category: Ophthalmology | ||||||
| 10/24/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: DRY EYE | ||||||
| 10/17/2023 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Ophthalmology | ||||||
| 08/01/2023 | Sun Pharmaceutical Industries Inc. | Cequa (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Ophthalmology | ||||||
| 06/05/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $149.00 | General |
| Category: TEPEZZA | ||||||
| 06/01/2023 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Ophthalmology | ||||||
| 05/10/2023 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $13.91 | General |
| 05/08/2023 | Bausch & Lomb Americas Inc. | PROLENSA (Drug), VYZULTA | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Ophthalmology | ||||||
| 03/14/2023 | Bausch & Lomb Americas Inc. | TORIC (Device) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 648 | 830 | $137,956 | $44,890 |
| 2022 | 7 | 838 | 1,014 | $152,212 | $58,597 |
| 2021 | 6 | 734 | 793 | $129,597 | $52,884 |
| 2020 | 8 | 699 | 751 | $115,838 | $49,598 |
Total Patients
2,919
Total Services
3,388
Medicare Billing
$205,969
Procedure Codes
30
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 241 | 301 | $60,187 | $19,988 | 33.2% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 118 | 118 | $33,022 | $9,365 | 28.4% |
| 83861 | Microfluid analysis of tears | Office | 2023 | 59 | 160 | $5,635 | $3,525 | 62.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 31 | 31 | $8,662 | $2,956 | 34.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 46 | 48 | $9,437 | $2,914 | 30.9% |
| 92134 | Imaging of retina | Office | 2023 | 60 | 69 | $7,326 | $2,208 | 30.1% |
| 92133 | Imaging of optic nerve | Office | 2023 | 68 | 78 | $7,675 | $1,997 | 26.0% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 13 | 13 | $4,274 | $1,405 | 32.9% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 12 | 12 | $1,740 | $533.21 | 30.6% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 376 | 377 | $80,390 | $29,931 | 37.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 209 | 286 | $43,073 | $18,139 | 42.1% |
| 92133 | Imaging of optic nerve | Office | 2022 | 86 | 106 | $8,478 | $2,790 | 32.9% |
| 83861 | Microfluid analysis of tears | Office | 2022 | 57 | 127 | $4,616 | $2,770 | 60.0% |
| 92134 | Imaging of retina | Office | 2022 | 71 | 79 | $7,693 | $2,271 | 29.5% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 27 | 27 | $6,328 | $2,099 | 33.2% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 12 | 12 | $1,635 | $596.94 | 36.5% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 377 | 380 | $77,186 | $31,055 | 40.2% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 150 | 177 | $23,969 | $12,029 | 50.2% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 49 | 49 | $11,484 | $4,467 | 38.9% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 75 | 93 | $7,265 | $2,520 | 34.7% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 69 | 79 | $7,818 | $2,390 | 30.6% |
| 92250 | Photography of the retina | Office | 2021 | 14 | 15 | $1,875 | $422.88 | 22.6% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 329 | 331 | $64,374 | $28,041 | 43.6% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 137 | 156 | $21,126 | $10,323 | 48.9% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 52 | 52 | $11,917 | $4,912 | 41.2% |
About David Anzai
David Anzai is a Optometrist healthcare provider based in Kahului, Hawaii. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548323298.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Anzai has received a total of $4,627 in payments from pharmaceutical and medical device companies, with $831.77 received in 2024. These payments were reported across 112 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($4,627).
As a Medicare-enrolled provider, Anzai has provided services to 2,919 Medicare beneficiaries, totaling 3,388 services with total Medicare billing of $205,969. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location Kahului, HI
- Active Since 12/17/2006
- Last Updated 03/03/2016
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1548323298
Products in Payments
- VYZULTA (Drug) $431.62
- INFUSE (Device) $421.10
- DURYSTA (Drug) $324.19
- XIIDRA (Drug) $276.64
- VUITY (Drug) $266.71
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $245.31
- BIOTRUE ONE DAY (Device) $233.07
- Cequa (Drug) $221.99
- Rhopressa (Drug) $176.68
- RXSIGHT CONTACT LENS (Device) $172.28
- TYRVAYA (Drug) $161.60
- LUMIGAN (Drug) $158.74
- TEPEZZA (Biological) $152.28
- ULTRA MULTIFOCAL TORIC (Device) $150.00
- TEPEZZA (Drug) $149.00
- PROLENSA (Drug) $147.13
- MIEBO (Drug) $144.34
- TearScience Lipiflow System (Device) $120.68
- INVELTYS (Drug) $110.06
- COMBIGAN (Drug) $61.06
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Kahului
Linda Nguyen, O.d, O.D
Optometrist — Payments: $9,566
Optometrist $9,566
Dr. Karsten Lee, O.d, O.D
Optometrist — Payments: $4,822
Optometrist $4,822
Krysta Landas, O.d, O.D
Optometrist — Payments: $2,308
Optometrist $2,308
Mrs. Samantha Kawa, O.d, O.D
Optometrist — Payments: $641.72
Optometrist $641.72
Dr. Loc Truong, O.d, O.D
Optometrist — Payments: $504.22
Optometrist $504.22